| Fiscal period | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|
| Period End Date | 3/31/2022 | 3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | 3/31/2017 | 3/31/2016 | 3/31/2015 | 3/31/2014 | 3/31/2013 |
|---|
| Revenues | 263,966.00 | 238,228.00 | 231,051.00 | 214,319.00 | 208,357.00 | 198,533.00 | 190,884.00 | 179,045.00 | 137,392.00 | 122,196.00 |
| Total Revenues | 263,966.00 | 238,228.00 | 231,051.00 | 214,319.00 | 208,357.00 | 198,533.00 | 190,884.00 | 179,045.00 | 137,392.00 | 122,196.00 |
| Cost of sales | 250,836.00 | 226,080.00 | 219,028.00 | 202,565.00 | 197,173.00 | 187,262.00 | 179,468.00 | 167,634.00 | 129,040.00 | 115,315.00 |
| Gross Profit | 13,130.00 | 12,148.00 | 12,023.00 | 11,754.00 | 11,184.00 | 11,271.00 | 11,416.00 | 11,411.00 | 8,352.00 | 6,881.00 |
| Goodwill impairment charge | 0.00 | 69.00 | 2.00 | 1,797.00 | 1,738.00 | 290.00 | 0.00 | 0.00 | -- | -- |
| Research and development | -- | -- | -- | -- | 125.00 | 341.00 | 392.00 | 392.00 | 457.00 | 433.00 |
| Selling | -- | -- | -- | -- | -- | -- | -- | -- | -- | 4,110.00 |
| Distribution | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Administrative | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling, Distribution, Research and Development and Administration Expenses | 10,537.00 | 8,849.00 | 9,182.00 | 8,437.00 | 8,138.00 | 7,447.00 | 7,379.00 | 7,901.00 | 5,388.00 | -- |
| Restructuring charges | 281.00 | 334.00 | 268.00 | 597.00 | 567.00 | 18.00 | 203.00 | 0.00 | -- | -- |
| Gain (loss) on sales of Business | -- | -- | -- | -- | (109.00) | 0.00 | (103.00) | -- | -- | (81.00) |
| Securities Litigation (charge) credit | -- | -- | -- | (37.00) | -- | -- | -- | (150.00) | (68.00) | (72.00) |
| Gain on Healthcare Technology Net Asset Exchange, net | -- | -- | -- | -- | 37.00 | 3,947.00 | -- | -- | -- | -- |
| Claims and litigation charges, net | (274.00) | (7,936.00) | (82.00) | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | (11,092.00) | (17,188.00) | (9,534.00) | (10,868.00) | (10,422.00) | (4,149.00) | 7,871.00 | 8,443.00 | (5,913.00) | 4,534.00 |
| Operating Income / (Loss) | 2,038.00 | (5,040.00) | 2,489.00 | 886.00 | 762.00 | 7,122.00 | 3,545.00 | 2,968.00 | 2,439.00 | 2,347.00 |
| Interest expense | 178.00 | 217.00 | 249.00 | 264.00 | 283.00 | 308.00 | 353.00 | 374.00 | 300.00 | 240.00 |
| Impairment of an Equity Investment | -- | -- | -- | -- | -- | -- | -- | -- | -- | 191.00 |
| Gain (Loss) on Investments, Net | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Loss from equity method investment in Change Healthcare | 0.00 | 0.00 | (1,108.00) | (194.00) | (248.00) | -- | -- | -- | -- | -- |
| Other income (loss) net | 259.00 | 223.00 | 12.00 | 182.00 | 130.00 | 77.00 | 58.00 | 63.00 | 32.00 | 34.00 |
| Loss on debt extinguishment | (191.00) | 0.00 | 0.00 | -- | (122.00) | 0.00 | 0.00 | -- | -- | -- |
| Income (loss) from continuing operations before income taxes | 1,928.00 | (5,034.00) | 1,144.00 | 610.00 | 239.00 | 6,891.00 | 3,250.00 | 2,657.00 | 2,171.00 | 1,950.00 |
| Current- Foreign | 240.00 | 181.00 | 142.00 | 152.00 | 205.00 | 122.00 | 90.00 | 101.00 | 193.00 | 46.00 |
| Current: Federal | 233.00 | (15.00) | 170.00 | (20.00) | 577.00 | 524.00 | 658.00 | 453.00 | 484.00 | (84.00) |
| Deferred: Federal | 88.00 | (562.00) | (204.00) | 223.00 | (767.00) | 767.00 | 95.00 | 195.00 | 24.00 | 538.00 |
| Deferred: Foreign | (38.00) | (142.00) | (33.00) | (78.00) | (118.00) | (49.00) | (73.00) | (77.00) | (18.00) | (7.00) |
| Current: State and local | 129.00 | 47.00 | 48.00 | 35.00 | 33.00 | 86.00 | 96.00 | 90.00 | 64.00 | 14.00 |
| Deferred: State and Local | (16.00) | (204.00) | (105.00) | 44.00 | 17.00 | 164.00 | 42.00 | 53.00 | 10.00 | 80.00 |
| Provision for Income Taxes | 636.00 | (695.00) | 18.00 | 356.00 | (53.00) | 1,614.00 | 908.00 | 815.00 | 757.00 | 587.00 |
| Continuing operations | 1,292.00 | (4,339.00) | 1,126.00 | 254.00 | 292.00 | 5,277.00 | 2,342.00 | 1,842.00 | 1,414.00 | 1,363.00 |
| Discontinued operations | (5.00) | (1.00) | (6.00) | 1.00 | 5.00 | (124.00) | (32.00) | (299.00) | (156.00) | (25.00) |
| Discontinued operation - gain on sale, net | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income (Loss) | 1,287.00 | (4,340.00) | 1,120.00 | 255.00 | 297.00 | 5,153.00 | 2,310.00 | 1,543.00 | 1,258.00 | 1,338.00 |
| Net loss attributable to noncontrolling interests (7) | 173.00 | 199.00 | 220.00 | 221.00 | 230.00 | 83.00 | 52.00 | 67.00 | (5.00) | -- |
| Dividends on Preferred Securities of Subsidiary Trust, Net of Tax Benefit | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net income attributable to common shareholders | 1,114.00 | (4,539.00) | 900.00 | 34.00 | 67.00 | 5,070.00 | 2,258.00 | 1,476.00 | 1,263.00 | 1,338.00 |
| Earnings Per Share (Basic) - Cont Ops | 7.35 | (28.26) | 5.01 | 0.17 | 0.30 | 23.50 | 9.96 | 7.66 | 6.19 | 5.81 |
| EPS (Basic) : Disc Ops | (0.03) | 0.00 | (0.03) | 0.00 | 0.02 | (0.55) | (0.14) | (1.29) | (0.68) | (0.10) |
| Discontinued operation - gain on sale, net | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Earnings Per Share (Basic) | 7.32 | (28.26) | 4.98 | 0.17 | 0.32 | 22.95 | 9.82 | 6.37 | 5.51 | 5.71 |
| Earnings Per Share (Diluted) - Cont Ops | 7.26 | (28.26) | 4.99 | 0.17 | 0.30 | 23.28 | 9.84 | 7.54 | 6.08 | 5.69 |
| Earnings Per Share (Diluted) - Disc Ops | (0.03) | 0.00 | (0.04) | 0.00 | 0.02 | (0.55) | (0.14) | (1.27) | (0.67) | (0.10) |
| Discontinued operation - gain on sale, net | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Earnings Per Share (Diluted) | 7.23 | (28.26) | 4.95 | 0.17 | 0.32 | 22.73 | 9.70 | 6.27 | 5.41 | 5.59 |
| Weighted average shares basic | 152.30 | 160.60 | 180.60 | 196.30 | 208.00 | 221.00 | 230.00 | 232.00 | 229.00 | 235.00 |
| Weighted average shares diluted | 154.10 | 160.60 | 181.60 | 197.30 | 209.00 | 223.00 | 233.00 | 235.00 | 233.00 | 239.00 |